Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis'. Together they form a unique fingerprint.

Medicine & Life Sciences